Shanghai Shyndec Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Yong Liu
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 2.3yrs |
Board average tenure | 3.6yrs |
Recent management updates
Recent updates
CEO
Yong Liu (55 yo)
less than a year
Tenure
Mr. Yong Liu is Vice Chairman of the Board of Shanghai Shyndec Pharmaceutical Co., Ltd. from April 28, 2021 and serves as President Since September 2024.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Vice Chairman of the Board & President | less than a year | no data | no data | |
VP & General Counsel | 2.6yrs | CN¥1.43m | 0.0015% CN¥ 240.4k | |
VP & Secretary of the Board of Directors | 13.3yrs | CN¥1.46m | 0.0015% CN¥ 240.4k | |
Vice President | 20.4yrs | CN¥1.43m | 0.0015% CN¥ 240.4k | |
Vice President | 2yrs | CN¥914.60k | 0.0015% CN¥ 240.4k | |
Chief Financial Officer | less than a year | CN¥344.90k | no data |
2.3yrs
Average Tenure
54.5yo
Average Age
Experienced Management: 600420's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Vice Chairman of the Board & President | 3.6yrs | no data | no data | |
Independent Director | 2yrs | CN¥240.00k | no data | |
Director | 2yrs | no data | no data | |
Director | 2yrs | no data | no data | |
Chairman | 5.8yrs | no data | no data | |
Supervisor | 5.8yrs | no data | 0.0015% CN¥ 240.4k | |
Independent Director | 5.8yrs | CN¥240.00k | no data | |
Chairman of the Supervisory Board | 5yrs | no data | no data | |
Director | 4.5yrs | no data | no data | |
Independent Director | 3.6yrs | CN¥240.00k | no data | |
Supervisor | 2yrs | no data | no data |
3.6yrs
Average Tenure
55yo
Average Age
Experienced Board: 600420's board of directors are considered experienced (3.6 years average tenure).